Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers

► HA-CMC use for adhesion prevention during surgery for ovarian cancer does not increase morbidity. ► HA-CMC is not associated with major postoperative surgical complications. ► HA-CMC use may increase the risk of pelvic abscess under certain circumstances.